Caxton Associates (UK)’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.73M Buy
24,438
+14,844
+155% +$1.11M 0.04% 253
2025
Q4
$757K Buy
9,594
+5,769
+151% +$457K 0.01% 414
2025
Q3
$315K Hold
3,825
0.01% 542
2025
Q2
$308K Hold
3,825
0.01% 546
2025
Q1
$307K Buy
+3,825
New +$318K 0.01% 623

Other funds holding MET

Caxton Associates (UK)'s MET Position: Q1 2026 in Review

Caxton Associates (UK) increased its MetLife (MET) stake by 155% in Q1 2026, buying an estimated $1.11M and bringing the position to 24,438 shares worth $1.73M. The position accounts for 0.04% of the portfolio, ranked #253.

Caxton Associates (UK) first reported a position in MET in Q1 2025 and has held it in 5 quarters since. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.

  • Caxton Associates (UK) held 24,438 shares of MetLife worth $1.73M as of Q1 2026.
  • Caxton Associates (UK) bought 14,844 MetLife shares in Q1 2026, an estimated $1.11M.
  • MetLife made up 0.04% of Caxton Associates (UK)'s portfolio in Q1 2026, its #253 holding.
  • Caxton Associates (UK) first reported a position in MetLife in Q1 2025 and has held it in 5 quarters since.
  • 1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on Caxton Associates (UK)'s 13F filing for Q1 2026, filed 14 May 2026.